Mid 2024, a multistakeholder workshop was organised by Regulatory Science Network Netherlands (RSNN) Special interest group (SIG) Advanced Therapies and Centre for Future Affordable Sustainable Therapy Development (FAST). The aim of the meeting was to investigate the need for a national ATMP (advanced therapy medicinal products) network in the Netherlands, including objectives, activities, relevant stakeholders, and governance. The full report of the workshop is now available, see: Report of the RSNN SIG Advanced Therapies and FAST workshop now available | Regulatory Science Network Netherlands